Issue 7 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

25

No.

7

July 26, 2002Jul 26, 2002

Free

DOWNLOAD THE PDF

New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

Study Finds No Link Between Pill And Breast Cancer Risk

Vasectomy Doesn’t Increase Prostate Cancer Risk

Drug Slows Tumor Growth In Metastatic Kidney Cancer

STI-571 Effects Are Lasting Against GI Stromal Tumors

Monoclonal Antibody Improves AML Response To Therapy

Protocols Approved During the Month of June 2002

Recent Issues

Volume 50 | Issue 15 - April 12, 2024

Volume 50 | Issue 14 - April 05, 2024

Volume 50 | Issue 13 - March 29, 2024

Volume 50 | Issue 12 - March 22, 2024

Volume 50 | Issue 11 - March 15, 2024

Volume 50 | Issue 10 - March 08, 2024